Nina Weiler

850 total citations
42 papers, 578 citations indexed

About

Nina Weiler is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Nina Weiler has authored 42 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 19 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Nina Weiler's work include Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (14 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Nina Weiler is often cited by papers focused on Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (14 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Nina Weiler collaborates with scholars based in Germany, United Kingdom and United States. Nina Weiler's co-authors include Stefan Zeuzem, Maria Hoppe‐Lotichius, Tim Zimmermann, Gerd Otto, Martin‐Walter Welker, Johannes Vermehren, Michael Heise, Daniel Foltys, Anja Lautem and Tania M. Welzel and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

Nina Weiler

40 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Weiler Germany 12 288 267 146 123 75 42 578
C.P. Strassburg Germany 11 288 1.0× 231 0.9× 135 0.9× 56 0.5× 86 1.1× 38 571
Hermien Hartog Netherlands 14 151 0.5× 95 0.4× 239 1.6× 141 1.1× 193 2.6× 50 676
D Faust Germany 14 166 0.6× 153 0.6× 175 1.2× 76 0.6× 115 1.5× 31 505
Chi-Hung Cheng Taiwan 13 121 0.4× 192 0.7× 134 0.9× 99 0.8× 269 3.6× 15 758
Sarah Shalaby Italy 16 439 1.5× 439 1.6× 120 0.8× 51 0.4× 60 0.8× 49 636
Ian Schreibman United States 14 316 1.1× 360 1.3× 240 1.6× 92 0.7× 86 1.1× 36 745
Meenu Bajpai India 15 377 1.3× 318 1.2× 111 0.8× 32 0.3× 37 0.5× 52 721
P. Wolf France 16 279 1.0× 252 0.9× 322 2.2× 203 1.7× 43 0.6× 41 789
Rohit Sawhney Australia 10 185 0.6× 221 0.8× 91 0.6× 44 0.4× 91 1.2× 24 452
Juliane Liese Germany 15 226 0.8× 203 0.8× 257 1.8× 97 0.8× 160 2.1× 48 722

Countries citing papers authored by Nina Weiler

Since Specialization
Citations

This map shows the geographic impact of Nina Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Weiler more than expected).

Fields of papers citing papers by Nina Weiler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Weiler. The network helps show where Nina Weiler may publish in the future.

Co-authorship network of co-authors of Nina Weiler

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Weiler. A scholar is included among the top collaborators of Nina Weiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Weiler. Nina Weiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antczak, Magdalena, Nina Weiler, Florian Rothweiler, et al.. (2025). Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers. Cancer Letters. 624. 217754–217754. 1 indexed citations
2.
3.
Steeb, Theresa, Lydia Reinhardt, Julia Hoffmann, et al.. (2022). One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website—A Mixed-methods Approach. Journal of Cancer Education. 38(4). 1264–1270. 1 indexed citations
4.
Weiler, Nina, Kerstin Laib Sampaio, Richard J. Stanton, & Christian Sinzger. (2022). Combined knockdown of RL13 and UL128 for release of cell-free infectivity from recent HCMV isolates. Journal of Virological Methods. 305. 114537–114537. 1 indexed citations
5.
Adam, Elisabeth, Eva Herrmann, Kai Zacharowski, et al.. (2020). Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis. World Journal of Gastroenterology. 26(17). 2097–2110. 5 indexed citations
6.
Yel, İbrahim, Andreas A. Schnitzbauer, Wolf O. Bechstein, et al.. (2019). Prevalence and Clinical Impact of Sinusitis in Liver Graft Recipients. 5(1). 0–0. 1 indexed citations
7.
Conti, Clara Benedetta, Nina Weiler, Giovanni Casazza, et al.. (2019). Feasibility and reproducibility of liver and pancreatic stiffness in patients with alcohol-related liver disease. Digestive and Liver Disease. 51(7). 1023–1029. 8 indexed citations
8.
Welker, Martin‐Walter, Nina Weiler, Wolf O. Bechstein, et al.. (2018). Key role of renal biopsy in management of progressive chronic kidney disease in liver graft recipients. Journal of Nephrology. 32(1). 129–137. 9 indexed citations
9.
Heise, Michael, Nina Weiler, Martin‐Walter Welker, et al.. (2018). Liver Transplantation in Acute-on-Chronic Liver Failure: Considerations for a Systematic Approach to Decision Making. Visceral Medicine. 34(4). 291–294. 5 indexed citations
10.
Peiffer, Kai‐Henrik, Johannes Vermehren, S. Süsser, et al.. (2018). Interferon-free treatment choice according to baseline RASs leads to high SVR rates in HCV genotype 1 infected patients. Journal of Infection and Chemotherapy. 24(7). 524–530. 5 indexed citations
11.
Gerber, Ludmila, Daniel Fitting, Nina Weiler, et al.. (2017). Evaluation of 2D- Shear Wave Elastography for Characterisation of Focal Liver Lesions. Journal of Gastrointestinal and Liver Diseases. 26(3). 283–290. 36 indexed citations
12.
Weiler, Nina, Stefan Zeuzem, & Martin‐Walter Welker. (2016). Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection. World Journal of Gastroenterology. 22(41). 9044–9044. 6 indexed citations
13.
Weiler, Nina, Marcos N. Eberlin, Daniel Foltys, et al.. (2013). Tacrolimus Effects and Side Effects After Liver Transplantation: Is There a Difference Between Immediate and Extended Release?. Transplantation Proceedings. 45(6). 2321–2325. 7 indexed citations
14.
Foltys, Daniel, Nina Weiler, Axel Heimann, et al.. (2013). Comparative Analysis of In Situ Versus Ex Situ Perfusion on Micro Circulation in Liver Procurement—An Experimental Trial in a Porcine Model. Transplantation Proceedings. 45(5). 1693–1699. 2 indexed citations
15.
Lautem, Anja, Michael Heise, Maria Hoppe‐Lotichius, et al.. (2013). Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma. International Journal of Oncology. 42(4). 1297–1304. 40 indexed citations
16.
Foltys, Daniel, Tim Zimmermann, Michael Heise, et al.. (2013). Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention‐to‐treat principle. Clinical Transplantation. 28(1). 37–46. 10 indexed citations
17.
Heise, Michael, Anja Lautem, Jörn M. Schattenberg, et al.. (2012). Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance. BMC Cancer. 12(1). 109–109. 87 indexed citations
18.
Weiler, Nina, et al.. (2012). Outcome in patients with long-term treatment in a surgical intensive care unit. Langenbeck s Archives of Surgery. 397(6). 995–999. 7 indexed citations
19.
Zimmermann, Tim, Maria Hoppe‐Lotichius, Andreas Körner, et al.. (2011). The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation. Transplant International. 24(11). 1059–1067. 3 indexed citations
20.
Büssow, Heinrich, et al.. (2007). A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy. Journal of Neuroscience Methods. 161(2). 223–233. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.P. Strassburg Breakdown of academic impact, for papers by Hermien Hartog Breakdown of academic impact, for papers by D Faust Breakdown of academic impact, for papers by Chi-Hung Cheng Breakdown of academic impact, for papers by Sarah Shalaby Breakdown of academic impact, for papers by Ian Schreibman Breakdown of academic impact, for papers by Meenu Bajpai Breakdown of academic impact, for papers by P. Wolf Breakdown of academic impact, for papers by Rohit Sawhney Breakdown of academic impact, for papers by Juliane Liese
Rankless by CCL
2026